77 related articles for article (PubMed ID: 3908619)
1. Clinical trials using polyadenylic-polyuridylic acid as an adjuvant to surgery in treating different human tumors.
Lacour J
J Biol Response Mod; 1985 Oct; 4(5):538-43. PubMed ID: 3908619
[TBL] [Abstract][Full Text] [Related]
2. Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.
Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
Eur J Surg Oncol; 1988 Aug; 14(4):311-6. PubMed ID: 3044833
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
Chirurgie; 1984; 110(4):418-24. PubMed ID: 6389040
[No Abstract] [Full Text] [Related]
4. Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.
Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
Br Med J (Clin Res Ed); 1984 Feb; 288(6417):589-92. PubMed ID: 6421391
[TBL] [Abstract][Full Text] [Related]
5. A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.
Ducret JP; Caillé P; Sancho Garnier H; Amiel JL; Michelson M; Hovanessian AG; Youn JK; Lacour F
J Biol Response Mod; 1985 Apr; 4(2):129-33. PubMed ID: 3998763
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)].
Lacour F; Lacour J; Spira A; Michelson M; Petit JY; Delage G; Contesso G; Merlin-Nahon E; Sarrazin D; Viguier J
Chirurgie; 1980 Nov; 106(9):737-43. PubMed ID: 7009093
[No Abstract] [Full Text] [Related]
7. A new adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer.
Lacour F; Lacour J; Spira A; Michelson M; Delage G; Petit JY; Viguier J
Recent Results Cancer Res; 1982; 80():200-6. PubMed ID: 7036283
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic trial of Poly(A).Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results].
Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
Chirurgie; 1988; 114(6):516-23. PubMed ID: 3067998
[No Abstract] [Full Text] [Related]
9. [New methods in the treatment of breast cancer].
Semiglazov VF
Vopr Onkol; 1997; 43(1):22-6. PubMed ID: 9133082
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).
Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J
J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429
[TBL] [Abstract][Full Text] [Related]
11. Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trial.
Lacour J; Laplanche A; Malafosse M; Gallot D; Julien M; Rotman N; Guivarc'h M; Roullet-Audy JC; Lasser P; Hautefeuille P
Eur J Surg Oncol; 1992 Dec; 18(6):599-604. PubMed ID: 1478293
[TBL] [Abstract][Full Text] [Related]
12. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
Fodor J; Polgár C; Németh G
Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
[TBL] [Abstract][Full Text] [Related]
13. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
Fisher B; Jeong JH; Anderson S; Wolmark N
J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Crivellari D; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Lindtner J; Fey MF; Senn HJ; Coates AS; Collins J; Goldhirsch A;
J Clin Oncol; 2003 Dec; 21(24):4517-23. PubMed ID: 14673038
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
20. Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid.
Khan AL; Larsen F; Heys SD; Eremin O
Eur J Surg Oncol; 1999 Dec; 25(6):574-9. PubMed ID: 10556002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
